Extracellular Vesicles as Tools for Crossing the Blood–Brain Barrier to Treat Lysosomal Storage Diseases
Giovanni Lerussi(Vall d'Hebron Institut de Recerca), Ibane Abasolo(Unknown), Marc Moltó‐Abad(Universitat Autònoma de Barcelona), Joaquin Seras‐Franzoso(Vall d'Hebron Institut de Recerca), Mireia del Toro(Universitat Autònoma de Barcelona), Guillem Pintos‐Morell(Hospital Universitari Germans Trias i Pujol), Verónica Villagrasa-Araya(Vall d'Hebron Institut de Recerca)
Cited by 15
Related Papers
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype
|Journal of Inherited Metabolic Disease|2015|236
Bacterial Inclusion Bodies: Discovering Their Better Half
|Trends in Biochemical Sciences|2017|181
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178